Records 1 - 22
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis.
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101.
Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis.
Medicine 2021 Mar 100 (10): e19713.
Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa
| Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis.
Thoracic cancer 2021 Feb .
Kobayashi Nobuaki, Katakura Seigo, Kamimaki Chisato, Somekawa Kohei, Fukuda Nobuhiko, Tanaka Katsushi, Watanabe Keisuke, Horita Nobuyuki, Hara Yu, Piao Hongmei, Kaneko Takes
| Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
BioMed research international 2020 2020 2380124.
Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa
| PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs.
Cancer biology & medicine 2018 Nov 15 (4): 434-442.
Bai Yuchen, Chen Xiaoxia, Hou Likun, Qian Jun, Jiang Tao, Zhou Caicun, Ciebiada Maci
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699.
Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
Journal of thoracic disease 2017 Aug 9 (8): 2560-2571.
Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang
| Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Oncotarget 2017 May 8 (20): 33922-33932.
Fan Gaowei, Zhang Kuo, Ding Jiansheng, Li Jinmi
| The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.
PloS one 2017 12 (8): e0182562.
Zhuang Rongyuan, Li Song, Li Qian, Guo Xi, Shen Feng, Sun Hong, Liu Tians
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134.
Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy
| Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Oncotarget 2016 Jun .
Ai Bo, Liu Huiquan, Huang Yu, Peng Pi
| KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies.
Oncotarget 2016 Jan .
Pan Wei, Yang Yan, Zhu Hongcheng, Zhang Youcheng, Zhou Rongping, Sun Xinch
| Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis.
Journal of cancer research and clinical oncology 2015 Aug 141 (8): 1427-39.
Ying Min, Zhu Xiaoxia, Chen Kexu, Sha Zhou, Chen Longh
| The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.
Medical oncology (Northwood, London, England) 2015 Mar 32 (3): 61.
Zhang Yaxiong, Fang Wenfeng, Yan Yue, Wang Mengyao, Kang Shiyang, Sheng Jin, Zhan Jianhua, Chen Nan, Hong Shaodong, Yang Yunpeng, Ma Yuxiang, He Dacheng, Qin Tao, Zhou Ting, Tang Yanna, He Xiaobo, Liang Wenhua, Zhang
| Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Jan 27 (1): 30-9.
Wang S, Wang
| KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (10): 4439-45.
Ying Min, Zhu Xiao-Xia, Zhao Yang, Li Dian-He, Chen Long-H
| The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.
OncoTargets and therapy 2014 7 1487-96.
Ying Hou-Qun, Wang Feng, He Bang-Shun, Pan Yu-Qin, Gao Tian-Yi, Xu Ye-Qiong, Li Rui, Deng Qi-Wen, Sun Hui-Lin, Wang Shu-K
| Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer.
PloS one 2013 8 (1): 1.
Li Y, Li Y, Yang T, Wei S, Wang J, Wang M, Wang Y, Zhou Q, Liu H, Chen J
| [Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010 Sep 13 (9): 882-91.
Han Chengbo, Zou Huawei, Ma Jietao, Zhou Yang, Zhao Jianz
| KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.
Lung cancer (Amsterdam, Netherlands) 2010 Sep 69 (3): 272-8.
Mao Chen, Qiu Li-Xin, Liao Ru-Yan, Du Fang-Bing, Ding Hong, Yang Wan-Chun, Li Jin, Chen Qi
| rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis.
Journal of cancer research and therapeutics 0 12 (2): 699-704.
Zhang Shi-Yan, Shi Ji